| The
whispersinthecorridors Online Print from origin : whispersinthecorridors.com > Archive > 4th December 2006 , Monday |
| What
people say about us ! ADVERTISE
ON-WHISPERSINTHECORRIDORS.COM Top Brass The Hindustan Latex Limited(HLL)of which Chairman is M.Ayyappan has ambitious plans.In an interview to "whispersinthecorridors.com"Mr.Ayyappan said " today HLL has nearly 10% share in the global condom market. The expansion of our production capacity by 25% is envisaged to enable us to maintain the global leadership for condoms. HLL is today one of the largest manufacturer of Condoms in the world, with an annual production capacity of over 1 billion condoms. The
new areas of business HLL plans to venture into are in the area of : Vaccines
, LifeSpring Hospital Network, and Women's Health Care Products. In reply to a question Mr.Ayyappan said "the HLL wishes to keep alive the dream of all humanity - of a healthier, happier world."HLL's major area of diversification has been in the area of Health Care. HLL has entered into an agreement with the Female Health Company (FHC) of the US, to market their product - FC female condom in India In partnership with Becton and Dickinson (BD) - one of the world's leading Health Care companies, HLL recently introduced Bsure - reuse prevention syringe for use in the curative segment. HLL is investing heavily in the area of Research and Development. It is setting up a national centre for Research in the area of Contraceptive products. HLL's LifeSpring Hospital is to provide cost effective quality care, particularly in the area of reproductive health for the low income population, The Company plans to set up the LifeSpring chain of hospitals in every major district in the country within next five years. Here are answers to questions raised by us. 1. What are your expansion plans at HLL? Hindustan Latex's (HLL) journey started with its incorporation as a corporate entity under the Ministry of Health and Family Welfare of the Government of India on March 1, 1966 HLL is today a multi-product, multi-unit organization addressing various public health challenges facing humanity. With a vast array of innovative products and social programmes launched, Hindustan Latex Ltd. (HLL) year after year is taking a step closer to its vision of "Innovating for Healthy Generations". HLL is today one of the largest manufacturer of Condoms in the world, with an annual production capacity of over 1 billion condoms. Hindustan Latex is the only company in the world manufacturing and marketing the widest range of Contraceptives. It is unique in providing a range of Condoms, including Female Condoms, Intra Uterine Devices, Oral Contraceptive Pills - steroidal, non-steroidal and emergency contraceptive pills; Contraceptive Cream, and Tubal Rings. HLL's major area of diversification has been in the area of Health Care. HLL has entered into an agreement with the Female Health Company (FHC) of the US, to market their product - FC female condom in India. FHC is the manufacturer of FC female condom, the only female controlled prevention technology approved by the US FDA and the WHO. FC is distributed in over 100 countries around the world. HLL is in talks with FHC, for a possible transfer of technology to enable production of FC Female Condoms in the country. In partnership with Becton and Dickinson (BD) - one of the world's leading Health Care companies, HLL recently introduced Bsure - reuse prevention syringe for use in the curative segment. This is a major step to address the public health challenge facing the nation. The Bsure syringe employs a unique plunger breaking mechanism that is 'clinician activated', to eliminate any possible reuse of the syringe. HLL had also earlier introduced the 'Autolok'- auto destructive syringe, for the national immunization programme.
HLL has also introduced Closed System Blood Bags that are integrated with Leukocyte Filter - called LD Bags. These bags are intended for leuko-depletion immediately upon collection of blood from donors at blood banks. Today, HLL's Health care product range include: Blood Collection Bags, Surgical Sutures, Auto Disable Syringes, Vaccines, Women's Health Care Pharma products, Hydrocephalus Shunt, Tissue Expanders, Needle Destroyers, Blood Bank equipment, Iron and Folic Acid Tablets, Sanitary Napkins, and Oral Rehydration Salts
HLL has today, three state of the art manufacturing facilities with ISO 9001, ISO 14001- quality and environmental management system certifications. HLL's Peroorkada Plant was also awarded the OHSAS 18001 Certification for its efficient Occupational Health and Safety Management System. Products manufactured at its Plants also have the 'CE' marking. HLL is investing heavily in the area of Research and Development. It is setting up a national centre for Research in the area of Contraceptive products. 3. Do you contemplate to diversify? If yes then list those areas.
HLL has ventured into the area of Vaccines - to take on the challenge posed by communicable diseases, which are responsible for a significant share of the global burden of diseases, particularly in developing nations. The need to have affordable high quality vaccines for preventing communicable diseases is a public health priority in India. The company has initially launched the marketing of Hepatitis B and Typhoid Vaccines. HLL's LifeSpring Hospital is to provide cost effective quality care, particularly in the area of reproductive health for the low income population, The first LifeSpring Hospital was launched at Hyderabad in December 2005. HLL has since set up hospitals at Kanpur and Agra in UP. The Company plans to set up the LifeSpring chain of hospitals in every major district in the country. This is a unique social franchising initiative for creating access to good quality reproductive health services to poor people, at affordable prices. HLL had set up last year, a dedicated 'Women's Health Care Pharma Division' to cater to the reproductive Health Care needs of women - covering all age groups. The division will focus initially on the Gynaec segment, the products of which will be promoted through Doctors. All products for this Division are being manufactured at HLL's Kanagala Plant, near Belgaum in Karnataka. The product range will cover all sectors of women's health viz., autoimmune diseases, gynaecological infections and sexually transmitted diseases, hormone-related disorders (including menopause, contraception and sexual dysfunction), osteoporosis, cancer, and urinary bladder disorders. 4. What kind of competition do you envisage
for HLL and how would you As one of the key manufacturers of our product range we are fully confident of meeting any challenge of the competition. Our products have the highest quality standards and have a strong presence today in the global market. We are continuously upgrading our technology and directing
all our efforts to provide total customer satisfaction through continuous innovation
and improvements to our product mix. HLL today has nearly 10% share in the global condom market. The expansion of our production capacity by 25% is envisaged to enable us to maintain the global leadership for condoms. In the domestic sector HLL is the market leader. HLL commands a market share of over 65% in the nation's overall condom market. In the premium commercial segment HLL has acquired a market share of 19%. Yes, we have been investing heavily to sustain our leadership and towards increasing the user base for this prophylactic - which remains to this day the only product to combat STD's, including the deadly HIV. We have also the market leader for our Blood Transfusion bags, with a market share of over 40%. While focusing on quality we have been able to effectively implement cost management in all our operational areas. This is a key factor that will enable us to take on the competition particularly from countries such as China and the other countries in the region, in the global scenario. HLL is today the leading provider of contraceptive and health care products for various public health programmes managed by international agencies like - UNFPA, Mission Pharma, PSI and IDA. HLL is partnering with the Government of India in the National Rural Health Mission, Reproductive and Child Health Project and the National AIDS Control Programme. In the coming years,
through technical collaborations, marketing alliances and joint ventures, HLL
has drawn up a comprehensive plan to expand its portfolio in the area of Health
Care and Contraceptives - its core areas, to achieve rapid growth. The objective
is to achieve through this process a turnover of Rs.1000 crores by 2010. 5. Are you satisfied with the role of HLL in the social sector? HLL's contribution to social development is borne out through the various activities initiated by the company to reach out to the less privileged in our society. Hindustan Latex set up the Hindustan Latex Family Planning Promotion Trust (HLFPPT) a not for profit organization, for reaching health care and contraceptive aids to the poor and marginalized in the country. The Trust has also been undertaking well co-ordinated efforts in population stabilization and HIV AIDS control. HLFPPT programmes underway in AP, Bihar, Orissa, Jharkhand, Maharashtra and Kerala are based on intense behaviour change communication based models. The Trust also manages the largest social marketing programme in the country with a rural coverage of over 30,000 villages, with population below 5000. HLFPPT has been implementing the HIV AIDS Control Programme in partnership with Bill and Melinda Gates Foundation, in nine districts of Coastal Andhra Pradesh and partnering with NACO and State AIDS Control Societies in the states of Kerala, AP, MP and Orissa. Condom promotion programmes are also being implemented among the populations vulnerable to HIV in the states of Maharashtra, AP and Kerala. The Trust is expanding the Life Spring Hospital Network through franchising, with assistance from development agencies and the Government of India. HLFPPT also does advocacy, research, communication and product development for NGO's and other Development Sector organizations. This serves to enhance the impact of their development programmes. The Trust has presently on hand a major initiative with OXFAM in India.
HLL is one of the principal organizations in the state that has been extending assistance to various Educational, Cultural and Social organizations for their various activities. HLL wishes to keep alive the dream of all humanity - of a healthier, happier world.
Figure
of 1977 batch IAS to be around 50 ! Dr Rajagopal is new NPA Director & Acting SS Home Desa gets UN assignment Justice Sabharwal may be next
NHRC Chairman Sanjeev Kumar to be JS Defence Three dozen IRS
officers quit the job MEA,
Finance ministry clash over foreign postings Cadre of Shruti Singh changed Siraj
Hussain is JS Food K P Singh to return to MP Government may appoint counsellers
in forces 60 IRS
officers empanelled for Commissioner rank Rajasthan govt neglects development Justice Sharma is new CJ
of Delhi High Court IPS changes in Uttar Pradesh FORUM Housing policy - Need for review The housing policy is evidently vividly skewed. The figures taken out from the site of the directorate of estates is really revealing. For the sake of comparison only officers having pay Rs18400/- and above as on 1/1/96 are being compared. Eg. Type Waiting(Tenure pool) Waiting (General pool) D I 38* 126(24500/- still waiting) * already allotted but request for change. Further it is seen that while in the case of tenure pool the officers who have become eligible only recently are getting allotment of Type DI and DII, the general pool officers who became eligible on 1/1/96 are still waiting! The logic of tenure pool is probably that the officers of all India services come for short duration (5 years or so) as against central and other services. But what about officers in the general pool who are to retire within 5 years? Such officers admittedly have tenure less than 5 years. These should also be considered in tenure pool by that logic. Is it that in this country for every thing people have to approach courts. Is it not the responsibility of decision makers to detach themselves from service considerations and frame policies? If they cannot detach themselves then the moot point is should they be allowed to frame such policies in which they are themselves a party. Raj So much for equality The constitution guarantees that equal work would grant equal pay. In the post of Deputy Secretary, for instance, an IAS officer on deputation, would get a higher salary whereas an officer of any other service will get less. So much for equality. Sanath Aaj Ki Aawaz Woefully
only kabhi kabhi paidaa hothe hai Kalam and Manmohan jaise insaan, Bharat Kumar CORPORATE WORLD India being developed in Maritime sector Mohan goes
as National Head VSNL to use Tata name 63 new GMs in RSP Naidu
is Director of NCCF Ahmed resigns
from Gillette India Dalal
is new CISCO President Another IRMA faculty member resigns THOUGHT OF THE WEEK Avoiding Holiday Stress |
|
Dr
Suresh Mehrotra has his lips sealed, if you have any whispers then send it to
us |
| ©
www.whispersinthecorridors.com. (ANN) All rights reserved. |